BIONIK LABORATORIES CORP. Other Income and Expense
BIONIK LABORATORIES CORP. reported Other Income and Expense of -$120.98 thousand for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-21.
Discontinued › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2023-06-21
- BIONIK LABORATORIES CORP. nonoperating income (expense) for the quarter ending 2023-03-31 was -$59.17K.
- BIONIK LABORATORIES CORP. nonoperating income (expense) for the quarter ending 2022-12-31 was -$32.81K.
- BIONIK LABORATORIES CORP. nonoperating income (expense) for the quarter ending 2022-09-30 was -$18.18K.
- BIONIK LABORATORIES CORP. nonoperating income (expense) for the quarter ending 2022-06-30 was -$10.83K.
- BIONIK LABORATORIES CORP. nonoperating income (expense) for fiscal 2023 was -$120.98K.
- BIONIK LABORATORIES CORP. nonoperating income (expense) for fiscal 2022 was -$434.80K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$59.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21 | -$91.98K derived: sum of 2 quarters · filed 2023-06-21 | -$110.15K derived: sum of 3 quarters · filed 2023-06-21 | -$120.98K 10-K · filed 2023-06-21 |
| 2022-12-31 | -$32.81K 10-Q · filed 2023-02-08 | -$50.98K derived: sum of 2 quarters · filed 2023-02-08 | -$61.82K 10-Q · filed 2023-02-08 | -$365.77K derived: sum of 4 quarters · filed 2023-06-21 |
| 2022-09-30 | -$18.18K 10-Q · filed 2022-11-09 | -$29.01K 10-Q · filed 2022-11-09 | -$332.96K derived: sum of 3 quarters · filed 2023-06-21 | -$588.37K derived: sum of 4 quarters · filed 2023-06-21 |
| 2022-06-30 | -$10.83K derived: 10-K 12 month − 3 quarters · filed 2023-06-21 | -$314.78K derived: sum of 2 quarters · filed 2023-06-21 | -$570.19K derived: sum of 3 quarters · filed 2023-06-21 | -$796.60K derived: sum of 4 quarters · filed 2023-06-21 |
| 2022-03-31 | -$303.95K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21 | -$559.36K derived: sum of 2 quarters · filed 2023-06-21 | -$785.77K derived: sum of 3 quarters · filed 2023-06-21 | -$434.80K 10-K · filed 2023-06-21 |
| 2021-12-31 | -$255.41K 10-Q · filed 2023-02-08 | -$481.82K derived: sum of 2 quarters · filed 2023-02-08 | -$130.84K 10-Q · filed 2023-02-08 | |
| 2021-09-30 | -$226.41K 10-Q · filed 2022-11-09 | $124.57K 10-Q · filed 2022-11-09 | ||
| 2015-03-31 | $6.39M 10-KT · filed 2016-06-30 |